A Phase I, Randomized, Double-Blind, Placebo-Controlled, 5-Period, Cross-Over Study Assessing the Effects of Lasmiditan on Simulated Driving Performance in Normal Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 17 Jan 2018
At a glance
- Drugs Lasmiditan (Primary) ; Alprazolam
- Indications Migraine
- Focus Therapeutic Use
- Sponsors CoLucid Pharmaceuticals; Eli Lilly
- 25 Jul 2017 Status changed from active, no longer recruiting to completed.
- 10 May 2017 Planned End Date changed from 1 May 2017 to 1 Jun 2017.
- 10 May 2017 Planned primary completion date changed from 1 May 2017 to 1 Jun 2017.